Utah Medical Products
UTMD
119 hedge funds and large institutions have $140M invested in Utah Medical Products in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 9 closing their positions.
66% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 29
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
20% more capital invested
Capital invested by funds: $118M → $140M (+$23M)
5.2% more ownership
Funds ownership: 65.54% → 70.74% (+5.2%)
2% more funds holding
Funds holding: 117 → 119 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$6.17M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.31M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.04M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$634K |
| 5 |
RWM
Ritholtz Wealth Management
New York
|
+$585K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$1.25M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$613K |
| 3 |
Millennium Management
New York
|
-$603K |
| 4 |
Renaissance Technologies
New York
|
-$598K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$592K |
UTMD Hedge Fund Activity: Q1 2026 in Review
119 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q1 2026, worth a combined $140M — up 20% from $118M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new UTMD positions and 9 closed out — a net gain of 4 holders — while 48 added to existing stakes and 29 trimmed.
The largest buyer was Brandes Investment Partners, adding an estimated $6.17M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $1.25M.
- 119 institutional investors held Utah Medical Products (UTMD) as of Q1 2026, up from 117 in Q4 2025.
- Funds reported $140M of Utah Medical Products stock for Q1 2026, up 20% quarter-over-quarter.
- 13 funds opened new Utah Medical Products positions in Q1 2026 and 9 closed out, a net change of +4 holders.
- The largest Utah Medical Products buyer in Q1 2026 was Brandes Investment Partners, an estimated $6.17M added.
- The largest Utah Medical Products seller in Q1 2026 was Hotchkis & Wiley Capital Management, an estimated $1.25M sold.
Based on aggregated 13F filings for Q1 2026.